EXTERNAUTICS
EXTERNAUTICS is an innovative biotech company established in 2007 to exploit the unique possibilities offered by the Reverse Proteomic YOMICS® Platform toward the identification and development of novel diagnostic and therapeutic markers for Oncology applications. The past ten years have seen a tremendous increase in the use of Monoclonal Antibodies for the treatment of cancer diseases. Herceptin and Erbitux are clear examples of the present trends of the cancer clinical therapy to target and kill tumor cells on the basis of specific protein markers present on the tumors. Yet, the frequency of tumor regression is still limited to a very low percentage of the patient population submitted to treatment.
EXTERNAUTICS
Industry:
Biotechnology
Founded:
2007-01-01
Address:
Siena, Toscana, Italy
Country:
Italy
Website Url:
http://www.externautics.com
Total Employee:
11+
Status:
Active
Contact:
+39 0577 1916275
Email Addresses:
[email protected]
Total Funding:
3.89 M USD
Technology used in webpage:
Font Awesome Nginx Baidu Analytics DynaDot
Similar Organizations
Hemarina
Hemarina is a biotechnology company focused on the research and development of oxygen carriers for medical applications.
Investors List
MPS Venture
MPS Venture investment in Venture Round - Externautics
Biofund
Biofund investment in Venture Round - Externautics
